Neurocognitive functions of heavy cannabis using schizophrenia patients

European Psychiatry

Volumn 27, Issue 5, 2012, Pages 365-368

  Lev Ran, S ^a,b   Segev, A ^a   Braw, Y ^a,c   Levkovitz, Y ^a,b  

^a SHALVATA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c ARIEL UNIVERSITY   (Israel)

Author keywords

Cannabis; Neurocognitive; Schizophrenia

Indexed keywords

CANNABIS;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; IMPULSIVENESS; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; TASK PERFORMANCE;

ADOLESCENT; ADULT; ATTENTION; COGNITION; HUMANS; MARIJUANA ABUSE; MARIJUANA SMOKING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84862527425     PISSN: 09249338     EISSN: 17783585     Source Type: Journal    
DOI: 10.1016/j.eurpsy.2011.04.010     Document Type: Article

References (23)

1. Addington J., Addington D. Substance abuse and cognitive functioning in schizophrenia. J Psychiatry Neurosci 1997, 22(2):99-104.
2. Braw Y., Bloch Y., Mendelovich S., Ratzoni G., Gal G., Harari H., et al. Cognition in young schizophrenia outpatients: comparison of first-episode with multiepisode patients. Schizophr Bull 2008, 34(3):544-554.
3. Carey K.B., Carey M.P., Simons J.S. Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status. J Nerv Ment Dis 2003, 191(5):300-308.
4. Caspari D. Cannabis and schizophrenia: results of a follow-up study. Eur Arch Psychiatry Clin Neurosci 1999, 249(1):45-49.
5. Cheniaux E., Landeira-Fernandez J., Lessa Telles L., Lessa J.L., Dias A., Duncan T., et al. Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. J Affect Disord 2008, 106(3):209-217.
6. Degenhardt L., Tennant C., Gilmour S., Schofield D., Nash L., Hall W., et al. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med 2007, 37(7):927-934.
7. DeRosse P., Kaplan A., Burdick K.E., Lencz T., Malhotra A.K. Cannabis use disorders in schizophrenia: effects on cognition and symptoms. Schizophr Res 2010, 120(1-3):95-100. [Epub ahead of print].
8. Dervaux A., Goldberger C., Gourion D., Bourdel M.C., Laqueille X., Loo H., et al. Impulsivity and sensation seeking in cannabis abusing patients with schizophrenia. Schizophr Res 2010, 123(2-3):278-280. [Epub ahead of print].
9. Dowson J.H., Blackwell A.D., Turner D.C., Harvey E., Malhotra T., Robbins T.W., et al. Questionnaire ratings of attention-deficit/hyperactivity disorder (ADHD) in adults are associated with spatial working memory. Eur Psychiatry 2007, 22(4):256-263.
10. D'Souza D.C., Abi-Saab W.M., Madonick S., Forselius-Bielen K., Doersch A., Braley G., et al. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction. Biol Psychiatry 2005, 57(6):594-608.
11. Grech A., Van Os J., Jones P.B., Lewis S.W., Murray R.M. Cannabis use and outcome of recent onset psychosis. Eur Psychiatry 2005, 20(4):349-353.
12. Hides L., Dawe S., Kavanagh D.J., Young R.M. Psychotic symptom and cannabis relapse in recent-onset psychosis. Prospective study. Br J Psychiatry 2006, 189:137-143.
13. Jockers-Scherubl M.C., Wolf T., Radzei N., Schlattmann P., Rentzsch J., Gomez-Carrillo de Castro A., et al. Cannabis induces different cognitive changes in schizophrenic patients and in healthy controls. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31(5):1054-1063.
14. Koskinen J., Lohonen J., Koponen H., Isohanni M., Miettunen J. Rate of cannabis use disorders in clinical samples of patients with schizophrenia: a meta-analysis. Schizophr Bull 2010, 36(6):1115-1130.
15. Moore T.H., Zammit S., Lingford-Hughes A., Barnes T.R., Jones P.B., Burke M., et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007, 370(9584):319-328.
16. Mueser K.T., Drake R.E., Wallach M.A. Dual diagnosis: a review of etiological theories. Addict Behav 1998, 23(6):717-734.
17. Ramaekers J.G., Kauert G., Theunissen E.L., Toennes S.W., Moeller M.R. Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol 2009, 23(3):266-277.
18. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., et al. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic catchment area (ECA) Study. JAMA 1990, 264(19):2511-2518.
19. Ruiz-Veguilla M., Gurpegui M., Barrigon M.L., Ferrin M., Marin E., Rubio J.L., et al. Fewer neurological soft signs among first episode psychosis patients with heavy cannabis use. Schizophr Res 2009, 107(2-3):158-164.
20. Solowij N., Stephens R.S., Roffman R.A., Babor T., Kadden R., Miller M., et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002, 287(9):1123-1131.
21. Yucel M., Solowij N., Respondek C., Whittle S., Fornito A., Pantelis C., et al. Regional brain abnormalities associated with long-term heavy cannabis use. Arch Gen Psychiatry 2008, 65(6):694-701.
22. Yucel M., Bora E., Lubman D.I., Solowij N., Brewer W.J., Cotton S.M., et al. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr Bull 2010, [Published online: 25 July 2010]. 10.1093/schbul/sbp079.
23. Zuardi A.W., Crippa J.A., Hallak J.E., Moreira F.A., Guimaraes F.S. Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug. Braz J Med Biol Res 2006, 39(4):421-429.